Randomized phase II study of concurrent and sequential combinations of rituximab (R) plus CHOP (R-CHOP) in untreated indolent B-NHL: 7-year follow-up results
暂无分享,去创建一个
Y. Ohashi | M. Ogura | T. Kinoshita | K. Tobinai | K. Itoh | Y. Morishima | Takashi Watanabe | T. Igarashi | T. Hotta